Stabilized Silver-Gold Nanoparticle Compositions for Antimicrobial Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for dermatological conditions and infections, such as acne, MRSA, and other microbial-related issues, face limitations due to antibiotic resistance and the lack of effective antiviral options, often resulting in inadequate treatment and potential for serious complications, especially in vulnerable populations.
Innovation Solution
Development of stabilized multi-component nanoparticle compositions comprising spherical and coral-shaped metal nanoparticles, specifically silver and gold, with controlled particle sizes and distributions, combined with stabilizing agents, to effectively target and deactivate microbes without harming human tissues, allowing for topical or injectable applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are used to treat bacterial infections, then microbial growth is inhibited, but microbial resistance develops reducing treatment effectiveness
Solution Approach 1:
The patent changes the fundamental parameter of antimicrobial action from chemical (antibiotics) to physical (nanoparticle-mediated mechanisms including reactive oxygen species generation, membrane disruption, and catalytic activity). This parameter change bypasses microbial resistance to antibiotics while maintaining effective pathogen killing.
Solution Approach 2:
The invention uses composite nanoparticle systems combining metal cores (silver, gold) with stabilizing agents and functional coatings. These composite structures provide both antimicrobial activity and controlled delivery, overcoming the limitations of single-component antibiotic treatments.
2Reliability
If strong antimicrobial agents are used to kill pathogens, then infection is eliminated, but harm to human tissues increases
Solution Approach 1:
The nanoparticle compositions exhibit local quality by concentrating antimicrobial activity at the infection site through targeted application and cellular uptake. The particles selectively interact with microbial cells while minimizing damage to host tissues through size-dependent biodistribution and selective cellular internalization.
Solution Approach 2:
The patent utilizes size parameter control of nanoparticles (typically 1-100 nm) to achieve selective toxicity. The nanoscale dimensions enable penetration of microbial cell walls and membranes while the small size allows renal clearance, reducing accumulation and systemic toxicity to human tissues.
3Reliability
If nanoparticle compositions are used to target microbes selectively, then pathogen killing is enhanced, but complexity of composition increases
Solution Approach 1:
The nanoparticle compositions serve multiple functions simultaneously: antimicrobial killing, anti-inflammatory activity, and immunomodulation. This multi-functionality reduces the need for separate treatment agents while maintaining selective pathogen targeting through the inherent properties of metal nanoparticles.
Solution Approach 2:
Stabilizing agents and functional coatings on nanoparticle surfaces act as intermediaries that provide biocompatibility, control particle aggregation, and enable targeted delivery. These intermediary layers facilitate selective pathogen interaction while protecting human tissues from direct nanoparticle toxicity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoparticle compositions demonstrate enhanced antimicrobial efficacy, providing targeted and selective killing of pathogens while minimizing harm to human cells, offering a prophylactic and therapeutic solution for various dermatological and tissue infections, including MRSA, with potential for prolonged antimicrobial activity.
Implementation Method 1
the nanoparticle compositions and methods are believed to work, at least in part, by catalytically denaturing proteins in the microbial cell that contain exposed disulfide bonds
Implementation Method 2
stabilized multi-component antimicrobial nanoparticle compositions
Data Source
Figure 1A
Figure 1B~1C
Figure 2A
AI summary
Stabilized multi-component antimicrobial compositions for treating tissue diseases, infections or conditions include a first and second set of differently sized and/or differently shaped metal nanoparticles, and a stabilizing agent. Compositions and treatment methods may be used for treating tissue diseases, infections or conditions caused by microbial infections, such as bacteria, viral, and/or fungal infections, or for preventing the infection of a wound, such as a cut, abrasion, ulcer, lesion, sore, and the like. The compositions and treatment methods disclosed herein may also be used as a prophylactic, and in some embodiments may be applied to otherwise healthy tissue in order to prevent or reduce the occurrence of a tissue disease, infection or condition.